Advertisement
Screener

Tenaya Therapeutics, Inc. (TNYA) Executive Pay versus Performance: Pay versus Performance

Tenaya Therapeutics, Inc. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed

Similar stocks

Stock NameCountryMarket CapPE Ratio
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99